I agree that this site is using cookies. You can find further informations here.
X
Christophersen, Palle
83  results:
Search for persons X
?
1

Distinct neurodevelopmental and epileptic phenotypes associ..:

Mohammadi, Nazanin Azarinejad ; Ahring, Philip Kiær ; Yu Liao, Vivian Wan...
eBioMedicine.  106 (2024)  - p. 105236 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pharmacological Profiling of KATP Channel Modulators: An Ou..:

Dyhring, Tino ; Jansen-Olesen, Inger ; Christophersen, Palle.
Pharmaceuticals.  16 (2023)  2 - p. 225 , 2023
Link: https://doi.org/10.3390/..
 
?
3

The shortcoming of using glibenclamide in exploratory clini..:

Christophersen, Palle ; Dyhring, Tino
Cephalalgia.  43 (2023)  12 - p. , 2023
Link: https://doi.org/10.1177/..
 
?
4

Retroviral glycoprotein-mediated immune suppression via the..:

Laska, Magdalena J. ; Moeller, Jesper Bonnet ; Graversen, Jonas Heilskov...
Clinical Immunology.  242 (2022)  - p. 109081 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Comparison of The Novel KCa3.1 Inhibitor SAN903 with Ninted..:

Amrutkar, Dipak ; Boddum, Jessica ; Jacobsen, Thomas...
The FASEB Journal.  35 (2021)  S1 - p. , 2021
Link: https://doi.org/10.1096/..
 
?
6

Recent Developments in the Pharmacology of Epithelial Ca2 +..:

, In: Studies of Epithelial Transporters and Ion Channels; Physiology in Health and Disease,
Nardi, Antonio ; Olesen, Søren-Peter ; Christophersen, Palle - p. 967-1010 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Characterization of AN6001, a positive allosteric modulator..:

van Hout, Marloes ; Klein, Jessica ; Ahring, Philip K....
Biochemical Pharmacology.  174 (2020)  - p. 113788 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Four phase 1 trials to evaluate the safety and pharmacokine..:

Bergmann, Troels K. ; Stage, Tore B. ; Stenvang, Jan...
Basic & Clinical Pharmacology & Toxicology.  127 (2020)  4 - p. 329-337 , 2020
Link: https://doi.org/10.1111/..
 
?
9

Characterization of AN317, a novel selective agonist of α6β..:

Sandager-Nielsen, Karin ; Ahring, Philip K. ; Klein, Jessica...
Biochemical Pharmacology.  174 (2020)  - p. 113786 , 2020
Link: https://doi.org/10.1016/..
 
?
10

KV7.2–7.5 Channel‐Activation Contributes to Bladder Relaxat..:

Dalsgaard, Thomas ; Strøbæk, Dorte ; Christophersen, Palle
The FASEB Journal.  32 (2018)  S1 - p. , 2018
Link: https://doi.org/10.1096/..
 
?
11

Identification of new molecular targets for PET imaging of ..:

Villa, Alessandro ; Klein, Barbara ; Janssen, Bieneke...
Theranostics.  8 (2018)  19 - p. 5400-5418 , 2018
Link: https://doi.org/10.7150/..
 
?
12

Quantification of the functional expression of the Ca2+-act..:

Blomster, Linda V. ; Strøbaek, Dorte ; Hougaard, Charlotte...
Glia.  64 (2016)  12 - p. 2065-2078 , 2016
Link: https://doi.org/10.1002/..
 
?
13

Kv7 channels as targets for anti-epileptic and psychiatric ..:

Grunnet, Morten ; Strøbæk, Dorte ; Hougaard, Charlotte.
European Journal of Pharmacology.  726 (2014)  - p. 133-137 , 2014
Link: https://doi.org/10.1016/..
 
?
14

Characterization of a novel high-potency positive modulator..:

Dalby-Brown, William ; Jessen, Carsten ; Hougaard, Charlotte...
European Journal of Pharmacology.  709 (2013)  1-3 - p. 52-63 , 2013
Link: https://doi.org/10.1016/..
 
?
15

CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Do..:

Herrik, Kjartan F. ; Redrobe, John P. ; Holst, Dorte...
Frontiers in Pharmacology.  3 (2012)  - p. , 2012
Link: https://doi.org/10.3389/..
 
1-15